GLP-1 injections are weekly subcutaneous medications — most commonly semaglutide or tirzepatide — used for weight management and blood sugar control. They’re typically self-injected with a small needle into the fatty layer just under the skin. You got the prescription. Maybe you had a telehealth visit, answered questions about your health history, and a licensed provider determined that GLP-1 therapy fits your treatment plan. Then a package arrives at your door containing a small glass vial, a set of insulin syringes, and a sheet of instructions-and you realize you’ve never given yourself an injection before.
This guide is for patients who have been prescribed GLP-1 injection therapy, especially anyone new to self-injection or comparing affordable telehealth access. It covers the practical logistics most patients actually need: how to inject, where to inject, how to rotate injection sites, how to store and travel with your medication, what to do if you’re anxious or something seems off during an injection, and how to access GLP-1 injections affordably through telehealth. Provn offers compounded semaglutide injections and compounded tirzepatide injections as weekly subcutaneous injections through US-based telehealth, and this guide complements the specific instructions your provider gives you.
Because these medications can play an important role in obesity treatment and blood sugar management, knowing how to use, store, and source them correctly can affect both results and cost. This is not a deep dive into how GLP-1 agonists work at the hormone level or a review of clinical trials results. For that, see Provn’s article on how GLP-1 medications work for weight loss.
What Makes GLP-1 Weight Loss Medications Injections Instead of Pills?
GLP-1 medications mimic the hormone GLP-1 in the body. They help the pancreas release insulin when blood sugar is high, work by slowing stomach emptying, and reduce appetite and food intake-which together promote weight loss and improve blood sugar levels. The two most commonly prescribed GLP-1 medications for weight management are semaglutide and tirzepatide.
The catch is that most of these medications are peptides — chains of amino acids that your digestive system would break down before they ever reached your bloodstream. That’s why most GLP-1 medications are self-administered via injection into the subcutaneous fat layer beneath your skin.
An oral semaglutide formulation exists (branded as Rybelsus, FDA-approved for type 2 diabetes) but requires strict fasting protocols — taking the pill on an empty stomach with a small sip of water, then waiting 30 minutes before eating or drinking anything else. This absorption challenge is why injectable formulations remain the standard for weight management therapy, where consistent dosing and predictable absorption matter for long-term results.
Injectable GLP-1s bypass the digestive system entirely, delivering the medication into the subcutaneous fat layer where it’s slowly absorbed into the bloodstream over the course of a week. This slow-release delivery is what makes weekly injections possible — a single dose provides steady medication levels for seven days.
For weekly injection-based GLP-1 therapy — the focus of this guide — subcutaneous delivery remains the standard approach for weight management.
The Compounded Vial Format: What You Actually Receive
When you fill a prescription through Provn’s pharmacy partners, you receive compounded semaglutide or compounded tirzepatide in a multi-dose glass vial along with separate sterile insulin syringes for your weekly injection. Tirzepatide is a dual GLP-1/GIP receptor agonist, offering a different mechanism than semaglutide alone.
This format is different from branded prefilled disposable pens like Ozempic and Wegovy (manufactured by Novo Nordisk) or Zepbound (manufactured by Eli Lilly). Those devices combine medication and delivery in one unit. Provn’s products are not those brands-they are compounded drugs prepared by a state licensed pharmacy under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.
Your vial will typically include:
- A colored cap over a rubber stopper
- A label showing the drug name, concentration, and active ingredient
- A beyond-use date and storage instructions
- The pharmacy’s contact information
You’ll use the same vial for multiple doses, drawing up your prescribed amount with a new syringe each week. The vial format gives your healthcare provider flexibility in titration-adjusting your dose as your body responds-and reduces packaging waste compared to single-use pens.
What to verify before every dose: Confirm the medication name and concentration match your prescription. Use only the syringe type and dose volume your provider specified. Never share vials or needles with anyone.
Important: Compounded semaglutide and compounded tirzepatide are not FDA approved. They are prepared by state-licensed compounding pharmacies and are not reviewed by FDA for safety, effectiveness, or quality in the same way as commercially manufactured drugs.
Vial vs. Prefilled Pen: Practical Differences
Whether you receive your GLP-1 medication as a compounded vial with syringe or as a branded prefilled pen affects your daily injection routine in several ways:
- Dose flexibility: Vials allow your provider to prescribe specific doses that may not match preset pen increments. This flexibility supports individualized titration — starting at a low dose and gradually increasing based on your response and tolerance.
- Volume awareness: With a vial, you draw the exact volume prescribed each week. This makes it easier to notice if you’re approaching the end of your supply. With pens, remaining doses can be harder to track without the vial’s clear liquid marker.
- Cost structure: Compounded vials typically contain multiple doses in a single vial, which affects packaging costs and shipping requirements. Prefilled pens are typically manufactured for single-week or multi-week use with individual pen cartridges.
- Storage footprint: A multi-dose vial takes up less refrigerator space than multiple prefilled pens. This matters for patients with limited refrigerator storage or those who travel frequently.
- Learning curve: Vials require you to draw up the dose yourself, which takes a few extra minutes and requires the syringe technique described above. Prefilled pens dial to your dose and inject with a button press, which some patients find simpler. Neither format is inherently better — the right choice depends on your provider’s clinical recommendation and personal preference.
How to Administer a GLP-1 Injection: Step-by-Step Guide
GLP-1 injection needles are very fine — typically 29-gauge to 31-gauge — designed specifically for subcutaneous delivery. Most patients describe the sensation as a brief pinch that’s over in seconds.
Step 1: Prepare your workspace
Wash your hands thoroughly with soap and water. Gather your supplies: medication vial, a new sterile syringe, alcohol pads, and a sharps container. Check the vial label for correct medication name, strength, and beyond-use date. Inspect the solution-it should be clear and free of particles or discoloration.
Step 2: Draw the dose
Remove the syringe cap. Pull back the plunger to draw in air equal to your prescribed dose. Clean the vial’s rubber stopper with an alcohol pad. Insert the needle through the stopper and inject the air into the vial. Invert the vial so the needle tip is submerged in liquid. Pull the plunger slowly until you reach the exact dose mark your provider ordered.
Step 3: Remove air bubbles
With the needle still in the vial, gently flick the syringe barrel to move any large bubbles toward the needle end. Push them back into the vial and re-draw to the correct line. Small pinhead bubbles are generally not a concern for subcutaneous injections.
Step 4: Prepare the injection site
Choose a recommended site (abdomen, thigh, or upper arm). Clean the area with an alcohol pad and let it dry completely. Do not inject through bruised, scarred, or irritated skin.
Step 5: Inject
Pinch a fold of skin at the chosen site. Insert the needle at a 90-degree angle for most adults. If you are very lean, your provider may recommend a 45-degree angle instead. Push the plunger steadily until all medication is delivered. Count slowly to five or ten, then withdraw the needle straight out.
Step 6: Aftercare
If there’s a drop of blood, apply gentle pressure with clean gauze-do not rub the injection site. Place the used needle directly into a sharps container. Never reuse needles or syringes.
This guidance is educational and does not replace training and instructions from your own healthcare provider or pharmacy.
Why Subcutaneous Injection Works for GLP-1 Medications
Subcutaneous injection — into the fatty layer just beneath the skin — is the standard delivery method for weekly GLP-1 medications. This tissue layer has a rich network of small blood vessels but slower absorption than muscle or vein tissue, which is exactly what these medications need.
Slow, steady absorption is what makes once-weekly dosing possible. The medication forms a depot in the fatty tissue and gradually releases into circulation over several days. This is fundamentally different from oral medications, which spike in the bloodstream shortly after absorption and then decline.
The subcutaneous layer also has fewer pain receptors than deeper tissue, which is why properly administered injections into the abdomen, thigh, or upper arm are typically well tolerated. If you feel sharp pain during injection, that may indicate the needle has gone too deep or into muscle tissue — pull back slightly and adjust your angle for future injections.
Most patients find injections become routine within three to four weeks. The initial hesitation before your first dose fades quickly once you’ve completed a few successful weekly injections.
Injection Sites and Rotation Strategy
A subcutaneous GLP-1 injection delivers medication into the fatty tissue just beneath the skin. Proper site selection ensures consistent absorption and reduces discomfort over months of treatment.
The three recommended injection site areas are:
- Abdomen: At least two inches away from the belly button, avoiding the waistline
- Front or outer thigh: Midway between knee and hip
- Outer upper arm: Best if someone else administers the injection
Research shows that absorption across these three sites is similar when injections reach the subcutaneous layer properly, though some data suggest thigh absorption may be marginally slower in the first hours after injection.
Why rotation matters: Repeatedly injecting the same small area can cause lipohypertrophy-firm, fatty lumps under the skin that interfere with medication absorption and reduce effectiveness. Move at least one finger-width from your last injection point each week.
A simple rotation pattern: left abdomen → right abdomen → left thigh → right thigh, then repeat. Keep a brief phone note or journal entry logging which site you used each week.
Avoid injecting into: scars, stretch marks, moles, tattoos, bruises, areas of redness, hard lumps, or any site showing signs of infection. Some users report injection site reactions like redness or itchiness-rotating consistently helps minimize these.
First-Timer Guidance: Managing GLP-1 Injection Anxiety
If the idea of injecting yourself makes your stomach tighten, you’re in good company. Needle anxiety is one of the most common concerns patients raise before starting injectable medications-and it’s one that nearly everyone moves past within the first few weeks.
The needles used for GLP-1 injections are designed specifically for subcutaneous delivery and are remarkably small: 30-gauge or 31-gauge, 5/16 inch long. They feel closer to a quick pinch than anything resembling a hospital needle.
Practical strategies that help:
Practice the motions with an empty syringe or water draw before your first real dose
Ice the site for 30–60 seconds beforehand to dull sensation (check with your provider first)
Breathe slowly-inhale for four counts, exhale for four, and inject on the exhale
Use distraction: music, a podcast, counting backward from ten
Schedule your first dose when you’re unhurried and calm, not squeezed between meetings
Having a trusted person present-in the room or on a video call-can provide real emotional support. You can also ask your Provn telehealth clinician to walk you through the process live during a follow up visit. For a broader look at what the first weeks of therapy feel like, read Provn’s guide on what to expect during your first month on GLP-1 therapy.
Troubleshooting Common GLP-1 Injection Issues
Once you start doing your own injections, small problems will come up. Most are minor and easily solved. Anything that concerns you warrants a call to your doctor.
Air bubbles in the syringe
Tiny pinhead bubbles are common and generally safe for subcutaneous injections. Large bubbles can affect dose accuracy-tap the barrel, push the bubble back into the vial, and re-draw to the correct mark.
Minor bleeding or bruising
A small drop of blood or a light bruise at the injection site is normal, especially with thinner needles. Apply gentle pressure. If bruising is large, painful, or happens repeatedly at rotated sites, contact your healthcare provider.
Injection site reactions
Mild redness, a small lump, or slight itchiness typically resolves within 24–48 hours. If a reaction is spreading, warm to the touch, or accompanied by fever, seek medical evaluation promptly.
Missed dose
If you realize within a day or two of your scheduled weekly injection, you may be able to take it-but always follow your specific medication guide and provider instructions. If too much time has passed, skip and resume on your next scheduled day. Consistency in dosing supports steady treatment progress.
Accidental needle stick
Wash the area immediately with soap and water. Dispose of the needle. Contact your provider, particularly if someone else was stuck.
Storage mishaps
If a vial was left out overnight or exposed to unusual temperatures, do not inject until you’ve contacted your pharmacy about that product’s stability. When in doubt, replace the vial.
The most common side effects of GLP-1 injections are gastrointestinal: nausea, vomiting, diarrhea, and constipation. Some patients experience upset stomach, dizziness, or increased heart rate. Less common but important other side effects include kidney disease and gallbladder issues, while severe risks may include pancreatitis and gallbladder disease. For a thorough breakdown, see Provn’s complete guide to GLP-1 side effects.
The Economics of GLP-1 Injection Access: Branded vs. Compounded
Cost is a real barrier. GLP-1 injections are prescribed for individuals with BMI 30 or higher, or with BMI 27 or higher when combined with a weight-related health condition. But branded weight loss medications like Ozempic, Wegovy, and Zepbound commonly cost hundreds to over a thousand dollars per month without insurance — a high cost that puts long-term treatment out of reach for many patients.
Insurance coverage remains inconsistent. Commercial plans more often cover GLP-1s for type 2 diabetes than for obesity alone, often requiring prior authorizations. Most commercial insurance plans do not cover GLP-1 medications for weight loss alone, with coverage more commonly available for type 2 diabetes management. Medicare currently covers GLP-1s for diabetes and certain related cardiovascular conditions, but coverage for weight loss alone remains limited.
Compounded GLP-1 medications can be significantly more affordable for self-paying patients through telehealth platforms. Compounding pharmacies bypass branded manufacturer marketing overhead and operate under direct-to-patient telehealth subscription models. Check current pricing on Provn’s product pages for subscription structures including monthly, 3-month, 6-month, and 12-month plans.
The regulatory framework: compounded medications are prepared under sections 503A and 503B of the FD&C Act. They are not FDA approved and are intended for patients whose needs aren’t met by available commercial options.
Beyond cost, GLP-1 medications deliver meaningful clinical benefits that extend past weight loss. Published clinical trials have shown that GLP-1 medications can produce meaningful weight loss when combined with lifestyle changes, though individual results vary considerably based on medication, dosage, adherence, and other factors. Beyond weight management, some GLP-1 medications have shown additional health effects in clinical research. Your provider can discuss which medications may be appropriate for your specific health profile and goals.
That said, loss of muscle mass can occur with sustained weight loss on GLP-1 medications, which is why providers often recommend combining treatment with exercise and adequate protein in your diet. HSA/FSA accounts can sometimes be used for GLP-1 expenses when prescribed for a medical indication-check with your plan administrator.
Alternatives for Patients Who Can’t or Don’t Want to Do Injections
Not everyone can or wants to use injectable medications. If needle anxiety is insurmountable, or if you have a condition that makes GLP-1 therapy inappropriate-such as a history of pancreatitis or pregnancy-alternatives exist.
Provn offers Low Dose Naltrexone (LDN) as a daily oral capsule taken at bedtime. LDN is not a GLP-1 medication and is not an injection. It works through an entirely different mechanism — modulating the opioid receptor system — and is prescribed off-label. LDN is not FDA approved for weight loss.
Patients who may benefit from discussing LDN with a Provn provider include:
Those with significant needle anxiety that GLP-1 therapy would compound
Those with a history of pancreatitis or other GLP-1 contraindications
Those with autoimmune conditions who haven’t responded to conventional weight management approaches
Those experiencing chronic inflammation that may contribute to metabolic difficulty
Those who have tried GLP-1 therapy without success or with intolerable side effects
LDN is taken as a daily oral capsule at bedtime, avoiding the storage, injection, and travel logistics associated with GLP-1 injectable therapy. Because it works through a different mechanism, LDN may be appropriate for patients whose weight management challenges have inflammatory or autoimmune components rather than purely metabolic ones.
Learn more about Low Dose Naltrexone as an alternative to GLP-1 injections.
How to Access GLP-1 Injections Through Telehealth with Provn
Provn’s telehealth process is designed to get you from intake to doorstep without an in-person clinic visit. Here’s how it works:
Complete an online intake – answer questions about your medical history, current medications, body weight, and health goals
Provider review – a licensed healthcare provider evaluates your information and may request recent labs or order new ones to determine whether GLP-1 therapy is appropriate
Prescription and fulfillment – if approved, your provider prescribes compounded semaglutide or compounded tirzepatide; prescriptions are filled by Provn’s partner state-licensed compounding pharmacies and shipped with refrigeration controls directly to your US address
Ongoing care – virtual follow up visits for dose adjustments, safety monitoring, and weight management support
If you’re comparing semaglutide vs tirzepatide, your Provn provider can help you decide which medication fits your treatment plan based on your health profile. Ready to begin? Get started with GLP-1 therapy.
Frequently Asked Questions About GLP-1 Injections
How do I choose the best day and time for my weekly GLP-1 injection?
Pick a consistent day that’s easy to remember. Morning or evening doesn’t matter-what matters is sticking to the same day each week. If you need to shift your injection day by a day or two, most protocols allow it as long as you maintain at least a few days between doses. Confirm timing with your healthcare provider.
Can I inject my GLP-1 medication before or after meals?
Yes. Injectable GLP-1s don’t require specific food timing before or after the injection itself. GLP-1 medications work by slowing digestion and increasing feelings of fullness regardless of meal timing. Inject whenever it fits your schedule. GLP-1 medications work by slowing digestion and increasing feelings of fullness regardless of meal timing.
What should I do if my GLP-1 vial looks cloudy or has particles?
Do not inject it. Cloudiness or visible particles may indicate degradation or contamination. Contact your pharmacy or provider for a replacement. The solution should appear clear and colorless.
Can I reuse a syringe or needle?
No. Single-use only, every time. Reusing needles increases infection risk and dulls the tip, making injections more painful. These injectable medications require sterile technique.
Is it safe to travel with GLP-1 injections?
Yes. Use an insulated cooler bag, keep medication in carry-on luggage, and bring your prescription documentation. See the storage and travel section above for a full checklist. GLP-1 injections are generally safe to transport when kept at proper temperatures.
How should I dispose of used needles and syringes?
Place used sharps immediately into an FDA-cleared sharps disposal container. If unavailable, use a heavy-duty plastic household container with a secure lid. Never throw loose needles in regular trash. Check local disposal regulations-many pharmacies and community programs accept full sharps containers.
When should I call my healthcare provider about an injection problem?
Contact your doctor if you notice persistent pain, spreading redness, warmth or pus at the injection site, signs of allergic reaction, or if you’re unsure about a dosing error. GLP-1 medications can cause dizziness or headaches, and while these are typically manageable, report anything that feels unusual or doesn’t resolve. Long term side effects and any concerning patterns should always be discussed at follow up visits.
Are GLP-1 injections safe during pregnancy?
GLP-1 medications are contraindicated during pregnancy. Animal studies have shown potential risks to fetal development. If you become pregnant or plan to, stop GLP-1 therapy and contact your provider immediately. Your doctor will help adjust your treatment plan and evaluate the safety of any other medications you’re taking.
What if I develop a serious side effect that requires stopping GLP-1 therapy?
Contact your healthcare provider immediately if you experience symptoms such as severe abdominal pain (especially radiating to the back), persistent vomiting, signs of an allergic reaction (rash, difficulty breathing, swelling), or symptoms of low blood sugar. Your provider will evaluate whether to adjust your dose, pause treatment, or transition to a different approach. Do not discontinue GLP-1 therapy without medical guidance unless you’re experiencing a serious adverse reaction, as sudden discontinuation can affect blood sugar management in patients with diabetes.
Can I switch between compounded semaglutide and compounded tirzepatide?
Switching between GLP-1 medications is possible under provider supervision. Your provider will typically recommend a washout period between medications and re-titrate your dose when switching. This is different from switching manufacturers of the same medication — the transition between semaglutide and tirzepatide involves different mechanisms (single vs. dual receptor action) and requires medical oversight.
Compounded semaglutide and compounded tirzepatide are not FDA approved. They are prepared by state-licensed compounding pharmacies under sections 503A and 503B of the FD&C Act. GLP-1 therapy is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). These medications require proper medical supervision and provider evaluation before starting therapy. All injection guidance in this article is educational. Follow the specific instructions from your healthcare provider and pharmacy. Individual results vary. Average weight loss depends on medication, dosage, adherence, diet, and exercise.
